COVID PAPERS

Covid 19 Research at Michigan

Published Papers

Bhaduri R, Kundu R, Purkayastha S, Kleinsasser M, Beesley LJ, Mukherjee B, Datta J. Extending the susceptible-exposed-infected-removed (SEIR) model to handle the false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy, Statistics in Medicine, 2022, 41(13):2317-2337. PMCID: PMC9035093.

Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. Journal of Infectious Diseases, 2022, jiac136. PMCID: PMC35429399.

Clark-Boucher D, Boss J, Salvatore M, Smith JA, Fritsche LG, Mukherjee B. Assessing the added value of linking electronic health records to improve the prediction of self-reported COVID-19 testing and diagnosis. PLoS One. 2022, 17(7):e0269017. doi:10.1371/journal. pone.0269017. PMID: 35877617.

Du J, Beesley L, Lee S, Zhou X, Dempsey W, Mukherjee B. Optimal diagnostic test allocation strategy during the COVID-19 pandemic and beyond. Statistics in Medicine, 2021, 10.1002/sim.9238. doi:10.1002/sim.9238. Epub ahead of print. PMCID: PMC8661762.

Fritsche LG, Jin W, Admon AJ, Mukherjee B. Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US. Preprint. medRxiv. 2022; 2022.10.21.22281356. doi:10.1101/2022.10.21.22281356. PMCID: PMC9681058.

Gu T, Mack JA, Salvatore M, Sankar SP, Valley TS, Singh K, Nallamothu BK, Kheterpal S, Lisabeth L, Fritsche LG, Mukherjee B. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System. JAMA Network Open, 2020, 3(10):e2025197, PMCID: PMC7578774.

Gu X, Mukherjee B, Das S, Datta, J. COVID-19 prediction in South Africa: Estimating the unascertained cases - the hidden part of the epidemiological iceberg. Journal of Statistical Research, 2021, 55(1), 267–291, doi.org/10.47302/jsr.20201550117.

Haupert SR, Shi X, Chen C, Fritsche LG, Mukherjee B. A Case-Crossover Phenome-wide Association Study (PheWAS) for Understanding Post-COVID-19 Diagnosis Patterns. J Biomed Inform. 2022;104237. doi:10.1016/j.jbi.2022.104237. Online ahead of print. PMCID: PMC9595430.

Roberts EK, Gu T, Wagner AL, Mukherjee B, Fritsche LG. Estimating COVID-19 Vaccination and Booster Effectiveness Using Electronic Health Records from an Academic Medical Center in Michigan. AJPM Focus, 2022, 1(1):100015. doi.org/10.1016/j.focus.2022.100015.

Salerno S, Zhao Z, Prabhu Sankar S, Salvatore M, Gu T, Fritsche LG, Lee S, Lisabeth LD, Valley TS, Mukherjee B. Patterns of repeated diagnostic testing for COVID-19 in relation to patient characteristics and outcomes. Journal of Internal Medicine, 2021 289(5):726-737, PMCID: PMC7753604.

Shi X, Li KQ, Mukherjee B. Current Challenges with the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes. Am J Epidemiol. 2022; kwac203. Online ahead of print. doi:10.1093/aje/kwac203.

Yu Y, Gu T, Valley TS, Mukherjee B, Fritsche LG. Changes in COVID-19-related outcomes, potential risk factors and disparities over time. Epidemiol Infect. 2021;149:e192. doi:10.1017/S0950268821001898, PMCID: PMC8376857.

Zhao Z, Salerno S, Shi X, Lee S, Mukherjee B, Fritsche LG. Understanding the Patterns of Serological Testing for COVID-19 Pre- and Post-Vaccination Rollout in Michigan. Journal of Clinical Medicine, 2021, 10(19):4341. doi:10.3390/jcm10194341. PMCID: PMC8509702.



India Covid 19 Research

Published Papers

Babu GR, Ray D, Bhaduri R, Halder A, Kundu R, Menon GI, Mukherjee B. COVID-19 Pandemic in India: Through the Lens of Modeling. Glob Health Sci Pract. 2021, 9(2):220-228. doi: 10.9745/GHSP-D-21-00233.PMCID: PMC8324184.

Bhaduri R, Kundu R, Purkayastha S, Kleinsasser M, Beesley LJ, Mukherjee B. Extending the susceptible-exposed-infected-removed (SEIR) model to handle the high false negative rate and symptom-based administration of covid-19 diagnostic tests: SEIR-fansy. ScienceOPEN, 2020, doi: 10.
1101/2020.09.24.20200238, 

Bhattacharyya R, Bhaduri R, Kundu R, Salvatore M, Mukherjee B.  Reconciling epidemiolocial models with misclassified case-counts for SARS-CoV-2 with seroprevalence surveys: A case study in Delhi, India. ScienceOPEN, 2020, doi: 10.1101/2020.07.31.20166249.

Bhattacharyya R, Kundu R, Bhaduri R, Ray D, Beesley LJ, Salvatore M, Mukherjee B. Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates. Scientific Reports, 2021, 11(1):9748, PMCID: PMC8105357.

Kuppalli K, Gala P, Cherabuddi K, Kalantri SP, Mohanan M, Mukherjee B, Pinto L, Prakash M, Pramesh CS, Rathi S, Pai NP, Yamey G, Pai M. India's COVID-19 crisis: a call for international action. Lancet. 2021, 397(10290):2132-2135. doi: 10.1016/S0140-6736(21)01121-1. PMCID: PMC8120195.

Purkayastha S, Bhattacharyya R, Bhaduri R, Kundu R, Gu X, Salvatore M, Ray D, Mishra S, Mukherjee B. A comparison of five epidemiological models for transmission of SARS-CoV-2 in India. BMC Infect Dis. 2021, 21(1):533. doi: 10.1186/s12879-021-06077-9. PMCID: PMC8181542.

Purkayastha S, Kundu R, Bhaduri R, Barker D, Kleinsasser M, Ray D, Mukherjee B. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India. BMC Res Notes. 2021, 14(1):262. doi: 10.1186/s13104-021-05652-2. PMCID: PMC8264482.

Purkayastha S, Salvatore M, Mukherjee B. Are women leaders significantly better at controlling the contagion during the COVID-19 pandemic? J Health Soc Sci. 2020, 5(2):231-240. PMCID: PMC7457824.

Ray D, Salvatore M, Bhattacharyya R, Wang L, Du J, Mohammed S, Purkayastha S, Halder A, Rix A, Barker D, Kleinsasser M, Zhou Y, Bose D, Song P, Banerjee M, Baladandayuthapani V, Ghosh P, Mukherjee B. Predictions, role of interventions and effects of a historic national lockdown in India's response to the COVID-19 pandemic: data science call to arms. Harv Data Sci Rev. 2020, 2020(Suppl 1):10.1162/
99608f92.60e08ed5. doi: 10.1162/99608f92.60e08ed5. PMCID: PMC7326342.

Salvatore M, Basu D, Ray D, Kleinsasser M, Purkayastha S, Bhattacharyya R, Mukherjee B. Comprehensive public health evaluation of lockdown as a non-pharmaceutical intervention on COVID-19 spread in India: national trends masking state-level variations. BMJ Open. 2020, 10(12):e041778. doi: 10.1136/bmjopen-2020-041778. PMCID: PMC7733201.

Salvatore M, Purkayastha S, Ganapathi L, Bhattacharyya R, Kundu R, Zimmermann L, Ray D, Hazra A, Kleinsasser M, Solomon S, Subbaraman R, Mukherjee B. Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience. Sci Adv, 2022, 8(24):eabp8621. doi:10.1126/sciadv.abp862. PMID: 35714183. 

Zimmermann L, Mukherjee B. Meta-analysis of nationwide SARS-CoV-2 infection fatality rates in India. PLOS Global Public Health. 2022 Sep 19;2(9):e0000897. doi: 10.1371/journal.pgph.0000897 

Zimmermann LV, Salvatore M, Babu GR, Mukherjee B. Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data. Am J Public Health. 2021, 111(S2):S59-S62. doi: 10.2105/AJPH.2021.306419. PMCID: PMC8495647.